Sage Therapeutics【SAGE】銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

5.54

買値

5.02

売値

6.00

出来高

4,252,555

4.95 日の範囲 5.62

4.62 52 週間の範囲 28.26

時価総額

338.9M

前日終値

5.00

始値

5.06

時刻

654

5.54

(formt)

最終取引時間

財務取引量

US$ 22,515,688

VWAP

5.2946

平均取引量 (3 か月)

816,344

発行済株式数

61,173,263

配当利回り

PER

-0.63

1 株当たり利益 (EPS)

-8.85

歳入

86.46M

純利益

-541.49M

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the study of the nervous system and brain to discover medicines to treat life-threatening, rare central nervous system disorders. The company's lead development program is SAGE-217 program which is in Phase 3 clinical tri... Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the study of the nervous system and brain to discover medicines to treat life-threatening, rare central nervous system disorders. The company's lead development program is SAGE-217 program which is in Phase 3 clinical trials for post-partum depression, essential tremor, Parkinson's disease, and major depressive disorder. The company is also developing several other compounds for treatment that are in the early stage of development. 詳細を表示

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.sagerx.com

本社

Wilmington, Delaware, USA

設立

Sage Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker SAGE. The last closing price for Sage Therapeutics was US$5. Over the last year, Sage Therapeutics shares have traded in a share price range of US$ 4.62 to US$ 28.26.

Sage Therapeutics currently has 61,173,263 shares in issue. The market capitalisation of Sage Therapeutics is US$305.87 million. Sage Therapeutics has a price to earnings ratio (PE ratio) of -0.63.

全体の流れ

ブルリッシュ

ネットプレミアム

130k

Calls / Puts

400.00%

買い / 売り

66.67%

OTM / ITM

25.00%

Sweeps比率

Sage Therapeutics Announces Topline Results from the Phase 2 DIMENSION Study of Dalzanemdor (SAGE-718) in the Treatment of Cognitive Impairment Associated with Huntington’s Disease

The Phase 2 DIMENSION Study did not meet its primary endpoint Dalzanemdor was generally well-tolerated; no new safety signals were observed Based on these data, the Company does not plan further...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.055	-0.983020554066	5.595	5.72	4.94	1309996	5.21650264	CS
4	0.69	14.2268041237	4.85	5.91	4.85	958669	5.45347408	CS
12	-1.72	-23.6914600551	7.26	8.7	4.62	816344	6.0352227	CS
26	-5.08	-47.8342749529	10.62	13.47	4.62	836249	8.08361269	CS
52	-16.47	-74.8296228987	22.01	28.26	4.62	953537	13.39507727	CS
156	-35.06	-86.354679803	40.6	59.99	4.62	832459	25.42688123	CS
260	-68.34	-92.5013535463	73.88	98.385	4.62	796594	36.46763277	CS

SAGE - Frequently Asked Questions (FAQ)

What is the current Sage Therapeutics share price?

The current share price of Sage Therapeutics is US$ 5.54

How many Sage Therapeutics shares are in issue?

Sage Therapeutics has 61,173,263 shares in issue

What is the market cap of Sage Therapeutics?

The market capitalisation of Sage Therapeutics is USD 305.87M

What is the 1 year trading range for Sage Therapeutics share price?

Sage Therapeutics has traded in the range of US$ 4.62 to US$ 28.26 during the past year

What is the PE ratio of Sage Therapeutics?

The price to earnings ratio of Sage Therapeutics is -0.63

What is the cash to sales ratio of Sage Therapeutics?

The cash to sales ratio of Sage Therapeutics is 3.97

What is the reporting currency for Sage Therapeutics?

Sage Therapeutics reports financial results in USD

What is the latest annual turnover for Sage Therapeutics?

The latest annual turnover of Sage Therapeutics is USD 86.46M

What is the latest annual profit for Sage Therapeutics?

The latest annual profit of Sage Therapeutics is USD -541.49M

What is the registered address of Sage Therapeutics?

The registered address for Sage Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Sage Therapeutics website address?

The website address for Sage Therapeutics is www.sagerx.com

Which industry sector does Sage Therapeutics operate in?

Sage Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
MYSZMy Size Inc	US$ 4.2001 (211.12%)	120.01M
NVNINVNI Group Ltd	US$ 8.26 (209.36%)	76.64M
TPICTPI Composites Inc	US$ 2.45 (100.82%)	33.95M
ICGIntchains Group Ltd	US$ 8.77 (88.60%)	527.61k
HSDTHelius Medical Technologies Inc	US$ 0.884851 (84.34%)	120.4M
CYNCYNGN Inc	US$ 0.4603 (-71.41%)	27.91M
MTEMMolecular Templates Inc	US$ 0.1502 (-57.09%)	8.75M
PRFXPainReform Ltd	US$ 5.15 (-53.85%)	2.94M
GALTGalectin Therapeutics Inc	US$ 1.03 (-48.50%)	9.27M
BCABBioAtla Inc	US$ 0.6923 (-41.82%)	6.25M
EDBLEdible Garden AG Inc	US$ 0.24 (65.06%)	354.32M
APTOAptose Biosciences Inc	US$ 0.28 (64.51%)	305.1M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.606999 (6.49%)	292.16M
NVDANVIDIA Corporation	US$ 134.70 (3.08%)	287.21M
PLTRPalantir Technologies Inc	US$ 80.55 (8.54%)	277.63M